COVID-19: FRANCE BANS HYDROXYCHLOROQUINE, SOUTH AMERICA, OUTPACE EUROPE AND US

Coronavirus (COVID-19) News Desk

Thu 28 May 2020:

The US coronavirus death toll passed 100,000 as the pandemic tightened its grip on South America, which is outpacing Europe and the United States in daily infections.

Global cases have surged to nearly 5.7 million, with more than 354,000 deaths, and the worrying acceleration of the disease in South America has marked the continent as the new hotspot.

Deaths in Brazil topped 25,000 on Wednesday, and its caseload is second only to the United States, where authorities have moved to ease lockdowns and help the battered economy, despite experts recommending they remain on guard for a resurgence of the disease.

“Don’t start leapfrogging over the recommendations of some of the guidelines because that’s really tempting fate and asking for trouble,” Anthony Fauci, one of the top US health advisers, told CNN.

Nearly 1.7 million Americans are known to have been infected with the disease, according to a Johns Hopkins University tally.

While scientists around the world are racing to develop a vaccine, parallel trials are under way to test treatments for COVID-19 symptoms.

Lockdowns in some form will remain necessary until a vaccine or treatment is available, experts have warned, but many governments are under immense pressure to provide relief as businesses and citizens grow weary and resentful of mass confinement.

Jair Bolsonaro, Brazil’s far-right president and a Trump ally, has slammed stay-at-home orders and played down the threat of the virus, saying the economic fallout of lockdowns causes more damage than the disease itself.

But infections in Brazil have surged past 411,000, and similar bad news continues to emerge from other South American countries.

Hydroxychloroquine ban

France said Wednesday it was banning the anti-malarial drug hydroxychloroquine as a treatment after the World Health Organization suspended its testing over fears of dangerous side effects.

The drug has proved controversial and divisive, with some leaders and governments still backing it — including President Trump, who said he had taken a course as a preventative measure because he had “heard a lot of good stories” about it.

Health authorities in Brazil and Senegal, and India’s top biomedical research body have said they will continue to use it for COVID-19 patients, but the US Food and Drug Administration has warned of serious side effects and poisoning.

The urgency of the coronavirus crisis has prompted some doctors to prescribe the drug despite a lack of research to demonstrate its effectiveness against the new coronavirus.

Didier Roualt, a French infectious disease specialist, insists he has successfully treated dozens of patients with hydroxychloroquine and the antibiotic azithromycin.

He has rejected a comprehensive study in The Lancet medical journal published last week which found that hydroxychloroquine actually increased the risk of death.

Think your friends would be interested? Share this story!

 

Leave a Reply

Your email address will not be published. Required fields are marked *